CMS proposes cutting Medicare 340B drug reimbursements to average sales price minus 33.4%, saving $4.55B in 2027. Hospital groups oppose; legal challenges expected.
A proposed rule would cut the rates by which Medicare pays hospitals for 340B drugs by more than a third, reviving a similar policy introduced …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Medicare takes another swing at 340B cuts to hospitals
Trump administration proposes rule to cut hospital profits on Medicare drugs
CMS' 2027 outpatient pay proposal brings 340B, site-neutral changes, to hospitals' dismay
Trump administration proposes a rule it says could save Medicare patients $1.1 billion on drugs
Trump Admin Proposes Rule It Says Could Save Medicare Patients $1.1B on Drugs
Trump Administration Targets Hospital Markups on Discounted Medicare Drugs, Says New Rule Could Save Pati
How hospitals profit from a program meant for low-income patients
CMS mulls tougher Medicare enrollment rules to combat fraud as part of 2027 home health payment rule
Gobierno de Trump propone norma que ahorraría a Medicare $1.100 millones en medicamentos
Lawmakers urge HHS to force Eli Lilly to provide 340B drug discounts to hospitals
Reducing Medicare payments for 340B drugs is the latest proposal focused on the hotly debated drug discount program.
The new rule would reduce the amount hospitals in the discounted drug program could be paid through Medicare by approximately 40%.
The Centers for Medicare and Medicaid Services’ annual outpatient hospital pay increase proposal has come with a potential major…
The Trump administration is proposing a new rule to keep hospitals from marking up discounted drugs for Medicare patients.
Under the proposed rule, CMS would change the formula for reimbursement
Placing new limits on the 340B drug discount program would be a fresh challenge for hospitals as they confront funding cuts.
